ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
1.630
-0.040 (-2.40%)
Feb 21, 2025, 4:00 PM EST - Market closed
ADC Therapeutics Market Cap
ADC Therapeutics has a market cap or net worth of $157.60 million as of February 21, 2025. Its market cap has decreased by -50.36% in one year.
Market Cap
157.60M
Enterprise Value
337.73M
1-Year Change
-50.36%
Ranking
Category
Stock Price
$1.63
Market Cap Chart
Since May 15, 2020, ADC Therapeutics's market cap has decreased from $2.04B to $157.60M, a decrease of -92.28%. That is a compound annual growth rate of -41.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 157.60M | -18.09% |
| Dec 31, 2024 | 192.41M | 43.49% |
| Dec 29, 2023 | 134.10M | -56.31% |
| Dec 30, 2022 | 306.95M | -80.20% |
| Dec 31, 2021 | 1.55B | -37.60% |
| Dec 31, 2020 | 2.48B | 21.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 801.31B |
| UnitedHealth Group | 421.12B |
| Johnson & Johnson | 389.43B |
| Novo Nordisk | 370.84B |
| AbbVie | 357.06B |
| Abbott Laboratories | 234.25B |
| AstraZeneca | 227.07B |
| Merck & Co. | 224.40B |